# A Study of Selumetinib in Patients With Kaposi's Sarcoma

> **NCT01752569** · PHASE1,PHASE2 · TERMINATED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 19 (actual)

## Conditions studied

- AIDS-related Kaposi's Sarcoma

## Interventions

- **DRUG:** Selumetinib

## Key facts

- **NCT ID:** NCT01752569
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06-15
- **Primary completion:** 2015-09-30
- **Final completion:** 2017-12-20
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2019-02-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01752569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01752569, "A Study of Selumetinib in Patients With Kaposi's Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01752569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*